Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Castle Biosciences Inc (CSTL)

  • Event
  • Aug. 08, 2022, 14:00 UTC
  • 97
  • 0 comments

Castle Biosciences - Castle Biosciences 2022 Investor Day

Comment Full text

Cyteir Therapeutics (CYT)

  • Event
  • Aug. 08, 2022, 13:20 UTC
  • 100
  • 0 comments

Cyteir Therapeutics - Corporate Presentation August 2022

Comment Full text

Guardant Health Inc. (GH)

  • Event
  • Aug. 08, 2022, 13:07 UTC
  • 92
  • 0 comments

Guardant Health, Inc. - UBS Genomics 2.0 and MedTech Innovations Summit Conference

Comment Full text

Castle Biosciences Inc (CSTL)

  • Event
  • Aug. 08, 2022, 13:07 UTC
  • 93
  • 0 comments

Castle Biosciences - Corporate Presentation

Comment Full text

Global Blood Therapeutics Inc (the company became a subdivision of the company Pfizer Inc (PFE)) (GBT)

  • Event
  • Aug. 08, 2022, 10:56 UTC
  • 24
  • 1 comments

(90% Positive) GLOBAL BLOOD THERAPEUTICS, INC. (GBT) Announces Clinical Development Update

Comment Full text

Karuna Therapeutics (was acquised by Bristol Myers Squibb (NYSE: BMY) on 18/03/2024) (KRTX)

  • Event
  • Aug. 08, 2022, 10:50 UTC
  • 22
  • 1 comments

(30% Negative) Karuna Therapeutics, Inc. (KRTX) Reports Q3 2022 Financial Results

Comment Full text

Reata Pharmaceuticals Inc (was by Biogen Inc. (Nasdaq: BIIB) on 26/09/2023) (RETA)

  • Event
  • Aug. 08, 2022, 10:45 UTC
  • 25
  • 1 comments

(10% Negative) Reata Pharmaceuticals, Inc. (RETA) Reports Q3 2022 Financial Results

Comment Full text

Karuna Therapeutics (was acquised by Bristol Myers Squibb (NYSE: BMY) on 18/03/2024) (KRTX)

  • Event
  • Aug. 08, 2022, 10:43 UTC
  • 23
  • 1 comments

(70% Positive) Karuna Therapeutics, Inc. (KRTX) Provides Update on reduction for Schizophrenia Trial met primary endpoint

Comment Full text

AstraZeneca (AZN)

  • Event
  • Aug. 08, 2022, 10:37 UTC
  • 20
  • 1 comments

(90% Positive) AstraZeneca (AZN) Announces Clinical Development Update (Form 6-K)

Comment Full text

HUTCHMED DRC (HCM)

  • Event
  • Aug. 08, 2022, 10:24 UTC
  • 20
  • 1 comments

(90% Positive) HUTCHMED DRC (HCM) Announces Clinical Development Update (Form 6-K)

Comment Full text
  • Previous
  • 124
  • 125
  • 126
  • 127
  • 128
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189146)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124506)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin